NL8700191A - Immunosuppressieve middelen, farmaceutische preparaten die ze bevatten en het toepassen van deze middelen. - Google Patents

Immunosuppressieve middelen, farmaceutische preparaten die ze bevatten en het toepassen van deze middelen. Download PDF

Info

Publication number
NL8700191A
NL8700191A NL8700191A NL8700191A NL8700191A NL 8700191 A NL8700191 A NL 8700191A NL 8700191 A NL8700191 A NL 8700191A NL 8700191 A NL8700191 A NL 8700191A NL 8700191 A NL8700191 A NL 8700191A
Authority
NL
Netherlands
Prior art keywords
compound
immunosuppressive
compounds
day
quinoline
Prior art date
Application number
NL8700191A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8700191A publication Critical patent/NL8700191A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL8700191A 1986-01-31 1987-01-27 Immunosuppressieve middelen, farmaceutische preparaten die ze bevatten en het toepassen van deze middelen. NL8700191A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8602372 1986-01-31
GB868602372A GB8602372D0 (en) 1986-01-31 1986-01-31 Organic compounds

Publications (1)

Publication Number Publication Date
NL8700191A true NL8700191A (nl) 1987-08-17

Family

ID=10592282

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8700191A NL8700191A (nl) 1986-01-31 1987-01-27 Immunosuppressieve middelen, farmaceutische preparaten die ze bevatten en het toepassen van deze middelen.

Country Status (14)

Country Link
EP (1) EP0231151A3 (ja)
JP (1) JPS62190123A (ja)
KR (1) KR870007126A (ja)
AU (1) AU6812387A (ja)
BE (1) BE1002394A3 (ja)
DE (1) DE3701891A1 (ja)
DK (1) DK47687A (ja)
FR (1) FR2595571A1 (ja)
GB (2) GB8602372D0 (ja)
IE (1) IE870228L (ja)
IT (1) IT1216787B (ja)
NL (1) NL8700191A (ja)
SE (1) SE8700361L (ja)
ZA (1) ZA87712B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8702680A (nl) * 1986-11-21 1988-06-16 Sandoz Ag Nieuwe benzogchinolinen en werkwijzen voor het bereiden en toepassen van deze verbindingen.
EP0327040A3 (de) * 1988-02-05 1990-11-28 Predrag Dr.Sc. Sikiric Verwendung von Dopamin und/oder von Dopamin-Agonisten zur Herstellung eines Arzneimittels für die Behandlung des Verdauungstrakts
GB2230440B (en) * 1989-02-09 1993-05-19 Sandoz Ltd Novel cyclosporin galenic forms
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
DE102005041613A1 (de) * 2005-09-01 2007-03-08 Ergonex Pharma Gmbh Pharmazeutische Zusammensetzungen zur Behandlung von Karzinoid-Syndrom

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867534A (en) * 1972-08-07 1975-02-18 Upjohn Co Dosage regimen
US3928612A (en) * 1974-10-02 1975-12-23 American Home Prod 1,2-Dihydro- and 1,2,3,4-tetrahydro-1-oxo-3-isoquinolinecarboxylic acid derivatives as anti-allergic agents
US4225600A (en) * 1977-05-04 1980-09-30 Fisons Limited Compositions and methods for treating certain skin conditions
CH632161A5 (it) * 1978-01-17 1982-09-30 Siphar Sa Composizione farmaceutica per il trattamento dell'asma.
DE3247514A1 (de) * 1982-12-20 1984-06-20 Schering AG, 1000 Berlin und 4709 Bergkamen Zytostatisch wirkende kombination
GB8422253D0 (en) * 1984-09-04 1984-10-10 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
SE8700361L (sv) 1987-08-01
DK47687A (da) 1987-08-01
DE3701891A1 (de) 1987-08-13
GB8701847D0 (en) 1987-03-04
EP0231151A3 (en) 1990-04-11
SE8700361D0 (sv) 1987-01-30
JPS62190123A (ja) 1987-08-20
IE870228L (en) 1987-07-31
DK47687D0 (da) 1987-01-29
ZA87712B (en) 1988-09-28
GB2185886A (en) 1987-08-05
GB8602372D0 (en) 1986-03-05
KR870007126A (ko) 1987-08-14
IT8747586A0 (it) 1987-01-30
BE1002394A3 (fr) 1991-01-29
IT1216787B (it) 1990-03-14
FR2595571A1 (fr) 1987-09-18
EP0231151A2 (en) 1987-08-05
AU6812387A (en) 1987-08-06

Similar Documents

Publication Publication Date Title
RU2396982C2 (ru) Эффективный способ использования лекарственных средств и способ предотвращения выраженности побочных эффектов
US5130141A (en) Compositions for and methods of treating muscle degeneration and weakness
DE60316798T2 (de) Zusammensetzungen und verfahren zur behandlung von diabetes
JPH04210915A (ja) 神経変性疾患用治療剤
US20010020036A1 (en) 5HT1 receptor agonists and metoclopramide for the treatment of migraine
LT4516B (lt) Rotamazės fermento inhibitoriai
SK161097A3 (en) Use of the immunophilin ligand for the preparation of agent to stimulate neuronal growth and regeneration at neuropathological conditions
JPH06508141A (ja) 新規免疫抑制化合物
JP2011256195A (ja) 虚血後腎不全の予防および処置並びに虚血腎臓の保護のためのａｔ１−レセプターアンタゴニスト
JP6806685B2 (ja) 急性放射線症候群を治療するための組成物及び方法
BR112021006033A2 (pt) Uso de um inibidor de um transportador da família ent no tratamento de câncer e combinação do mesmo com um antagonista do receptor de adenosina
TWI250021B (en) Pharmaceutical composition for use in the treatment of an inflammatory autoimmune disease or condition
US6436944B1 (en) Combination effective for the treatment of impotence
JPH04501267A (ja) 骨髄造血の刺激に有用なヘテロアリール―３―オキソ―プロパンニトリル誘導体
NL8700191A (nl) Immunosuppressieve middelen, farmaceutische preparaten die ze bevatten en het toepassen van deze middelen.
US20230277523A1 (en) Methods for inhibiting phosphate transport
AU3724400A (en) Methods and compositions for treating erectile dysfunction
US6291509B1 (en) Synergistic immunosuppressant composition containing a 2,2'-bi-1H-pyrrole compound
Osterman A COMPARISON BETWEEN PLACEBO, PIZOTIFEN AND 1‐ISOPROPYL‐3‐HYDROXY‐5‐SEMICARBAZONO‐6‐OXO‐2.3. 5.6.‐TETRAHYDROINDOL (DIVASCAN®) IN MIGRAINE PROPHYLAXIS
Marx Parkinson's Disease: Search for Better Therapies: More specific drugs, without the adverse side effects of L-dopa, are one of the goals of the research
EP3607948A1 (en) Tissue transglutaminase modulators for medicinal use
JPWO2005007191A1 (ja) 医薬組成物
JPH05504550A (ja) 免疫抑制剤として有用なピリミジン生合成インヒビター
EP0537291A1 (en) Method of treating nausea and emesis related to motion sickness
CA2167842A1 (en) Method of inhibiting the replication of human immunodeficiency viruses with substituted azaspiranes

Legal Events

Date Code Title Description
BV The patent application has lapsed
BV The patent application has lapsed